ArticleCureus2022

Prognostic Impact of Baseline Neutrophil-to-Eosinophil Ratio in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Therapy in Second or Later Lines.

Lucia Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.